Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02347007 · ClinicalTrials.gov registry record · NA

Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults

A NA study of Obesity and Overweight, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT02347007: Completed NA study of Obesity and Overweight, sponsored by Columbia University.

NCT02347007 is a NA study of Obesity and Overweight that has completed, run by Columbia University. The registered enrollment target is 26 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02347007, a NA study of Obesity and Overweight, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether introducing almonds into the diet of overweight and obese Blacks and Hispanics improves body composition, decreases liver fat, and lowers cardiovascular disease profile.

Primary Outcome

MRI will be used to provide information on total adipose tissue and all adipose tissue sub-compartments: visceral, subcutaneous, intermuscular.

Interventions

  • DIETARY_SUPPLEMENT Almond
  • DIETARY_SUPPLEMENT Cereal Bar

Study Locations (1)

New York

  • New York Nutrition Obesity Research Center - New York

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2014-10
Est. Completion 2019-03
Phase NA
Columbia University

958 total trials

What the finished NCT02347007 record still lists

NCT02347007 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower).

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Almond is the first listed.

NCT02347007 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02347007 about?

NCT02347007 is a clinical study titled "Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults". The purpose of this study is to determine whether introducing almonds into the diet of overweight and obese Blacks and Hispanics improves body composition, decreases liver fat, and lowers cardiovascular disease profile.

What is the current status of trial NCT02347007?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2014-10. Estimated completion is 2019-03.

What conditions does trial NCT02347007 study?

This clinical trial studies the following conditions: Obesity, Overweight, Fatty Liver, Metabolic Syndrome X.

What interventions are being tested in trial NCT02347007?

The interventions under investigation include: Almond (DIETARY_SUPPLEMENT), Cereal Bar (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02347007?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02347007 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02347007's enrollment target sits among peer trials

26 897th of 1053 higher than 151 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

  • NCT04913064 · 26 participants · NA

    Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02347007, the US trial registry maintained by the National Library of Medicine. NCT02347007 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.